Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |